Skip to main content

Find Clinical Trials

Home
Conditions
Neutropenia

Clinical trial condition

Neutropenia

Explore clinical trials studying Neutropenia. Study availability and eligibility vary by location and protocol.

73 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Neutropenia trial results

Completed

Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia

NCT00503854

Conditions: Agranulocytosis, Cytopenia, Fatigue, +9 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

NCT02178475

Conditions: Agranulocytosis, Breast Diseases, Breast Neoplasms, +12 more
Locations: Research Site Eggenburg, Austria

Research Site Graz, Austria

Research Site Leoben, Austria

Research Site Schwarzach im Pongau, Austria

View all 74 locations

View Trial Details

Completed

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

NCT00137787

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +5 more
Locations: Nagoya University Graduate School of Medicine Nagoya, Japan

View Trial Details

Completed

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

NCT03511820

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +6 more
Locations: Changhua Christian Hospital Changhua, Taiwan

Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan

Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan

Keelung Chang Gung Memorial Hospital Keelung, Taiwan

View Trial Details

Completed

Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia

NCT01581333

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +5 more
Locations: Hospital de Jerez Jerez de la Frontera, Cádiz, Spain

Hospital Vall d'Hebron Barcelona, Spain

Hospital Clínic Barcelona, Spain

Bellvitge University Hospital Barcelona, Spain

View Trial Details

Completed

Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

NCT00945555

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +5 more
Locations: Pfizer Investigational Site Kayseri, Turkey, Turkey (Türkiye)

Pfizer Investigational Site Kocaeli, Turkey, Turkey (Türkiye)

Pfizer Investigational Site Ankara, Turkey (Türkiye)

Pfizer Investigational Site Bursa, Turkey (Türkiye)

View Trial Details

Completed

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

NCT01813721

Conditions: Agranulocytosis, Breast Diseases, Breast Neoplasms, +17 more
Locations: Research Site Tweed Heads, New South Wales, Australia

Research Site Bendigo, Victoria, Australia

Research Site Shepparton, Victoria, Australia

Research Site Wodonga, Victoria, Australia

View all 90 locations

View Trial Details

Completed

Early Antibiotic Discontinuation in FUO

NCT02906254

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +9 more
Locations: CHRU de Brest Brest, France

View Trial Details

Completed

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

NCT01459653

Conditions: Adnexal Diseases, Agranulocytosis, B-cell Lymphoma, +61 more
Locations: Sandoz Investigational Site Innsbruck, Austria

Sandoz Investigational Site Kufstein, Austria

Sandoz Investigational Site Leoben, Austria

Sandoz Investigational Site Deurne, Belgium

View all 117 locations

View Trial Details

Completed

Study of Danggui Buxue Decoction in Preventing Neutropenia

NCT02005783

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +6 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details